Erratum: The emergence of an ethical duty to disclose genetic research results: International perspectives (European Journal of Human Genetics (2006) vol. 14 (1170-1178) 10.1038/sj.ejhg.5201690);The emergence of an ethical duty to disclose genetic research results: International perspectives

European Journal of Human Genetics

Volumn 14, Issue 11, 2006, Pages 1170-1178

  Knoppers, Bartha Maria ^a   Joly, Yann ^a   Simard, Jacques ^b   Durocher, Francine ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENETIC ANALYSIS; GENOMICS; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; INCIDENCE; LAW; LEGAL ASPECT; MEDICAL DECISION MAKING; MEDICAL ETHICS; PATIENT RIGHT; PHARMACOGENOMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RNA TRANSLATION; VALIDATION PROCESS;

EID: 33750388916     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201747     Document Type: Erratum

References (40)

1. Fernandez CV, Kodish E, Weijer C: Informing study participants of research results: An ethical imperative. IRB: Ethics Hum Res 2003; 25: 12-19.
2. Mann H: Research ethics committees and public dissemination of clinical trial consults. Lancet 2002; 359: 406-408.
3. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH): Good Clinical Practices - Consolidated Guidelines. Ottawa: Therapeutic Products Directorate, 1997. Available from: http://www.ncehr-cnerh.org/english/ gcp/.
4. Bookman EB, Langehorne AA, Eckfeldt JH et al: Reporting genetic results in research studies: Summary and recommendations of an NHLBI working group. Am J Med Genet 2006; 140 (Part A): 1033-1040.
5. Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG, Ioannidis JP: Establishment of genetic associations for complex diseases is independent of early study findings. Eur J Hum Genet 2004; 12: 762-769.
6. Renegar G, Webster CJ, Stuerzebecher S et al: Returning genetic research results to individuals: Points-to-consider. Bioethics 2006; 20: 24-36.
7. Banks TM: Misusing inAormed consent: a critique of limitations on research subjects' access to genetic research results. Sask Law Rev 2000; 63: 539-580.
8. European Federation of the International Epidemiologist Association (IEA): Good epidemiological practice (GEP) proper conduct in epidemiologic research. Berne: European Federation of the International Epidemiologist Association, 2002, (updated June 2004). Available from: http://www.dundee.ac.uk/iea/GoodPract.htm.
9. Medical Research Council of Canada, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada (IRSC, CRSNG and CRSH): Tri-council policy statement: ethical conduct for research involving humans. Ottawa: IRSC, CRSNG and CRSH; October 2005. Available from: http://www.pre.ethics.gc.ca/english/ pdf/TCPS%20October%202005_E.pdf.
10. Council for International Organization of Medical Sciences (CIOMS): International ethical guidelines for biomedical research involving human subjects. Geneva: Council for International Organization of Medical Sciences; November 2002. Available from: http://www.cioms.ch/ frame_guidelines_nov_2002.htm.
11. European Parliament. Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data (1995) O.J.L. 281/31 art. 12. Available from: http://www.cdt.org/privacy/eudirective/EU_Directive_html.
12. Knoppers BM, Chadwick R, Takebe H et al: HUGO urges genetic benefit-sharing. Commun Genet 2000; 3: 88-92.
13. Knoppers BM: Population genetics and benefit sharing. Commun Genet 2000; 3: 212-214.
14. Nuffield Council on Bioethics: Pharmacogenetics ethical issues. London: Nuffield Council on Bioethics, 2003, pp 22-23. Available from: http://www.nuffieldbioethics.org/go/ourwork/pharmacogenetics/ introduction.
15. World Medical Association (WMA): World medical association declaration of Helsinki, ethical principles for medical research involving human subjects. Edinburgh: World Medical Association, 2000. Available from: http://www.wma.net/e/policy/b3.htm.
16. Tumber MB, Dickersin K: PuAlication of clinical trials: accountability and accessibility. J Intern Med 2004; 256: 273.
17. European Commission: 25 Recommendations on the ethical, legal and social implications of genetic testing. Brussels: European Commission, 2004. Available from: http://europa.eu.int/comm/research/conferences/2004/ genetic/pdf/recommendations_en.pdf.
18. Council for International Organization of Medical Sciences (CIOMS): International guidelines for ethical review of epidemiological studies. Geneva: Council for International Organization of Medical Sciences, 1991. Available from: http://www.cioms.ch/ frame_1991_texts_of_guidelines.htm.
19. Council of Europe: Additional protocol to the convention on human rights and biomedicine concerning biomedical research. Strasbourg: Council of Europe, 2004 Available from: http://www.coe.int/T/E/Legal_affairs/ Legal_co-operation/Bioethics/Activities/Biomedical_research/ Protocol_Biomedical_research.pdf.
20. UNESCO, International Bioethics Committee (IBC): International declaration on human genetic data. Paris: UNESCO, International Bioethics Committee (IBC), 2003. Available from: http://portal.unesco.org/en/ev.php-URL_ID=17720&URL_DO= DO_TOPIC&URL_SECTION=201.html.
21. World Health Arganisation (WHO): Genetic databases: assessing the benefits and the impact on human and patient rights. Geneva: World Health Organisation, 2003. Available from: http://www.law.ed.ac.uk/ahrb/ publications/online/whofinalreport.doc.
22. Council of Europe: Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: Convention on human rights and biomedicine. Oviedo: Council of Europe, 1997. Available from: http://conventions.coe.int/treaty/en/ Treaties/Html/164.htm.
23. Lemmens T, Joly Y, KnoApers BM: Genetic and life insurance: a comparative analHsis. GenEdit 2004; 2: 1-15. Available from: http://www.humgen.umontreal.ca/int/GE_Arch_v.cfm?an=2004&no=2.
24. World Medical Association (WMA): World medical association declaration on the rights of the patient. Lisbon: World Medical Association, 1981. Available from: http://www.wma.net/e/policy/l4.htm.
25. World Health Organisation (WHO): Proposed international guidelines on ethical issues in medical genetics and genetic services. Geneva: World Health Organisation, 1997, Available from: http://whqlibdoc.who.int/hq/ 1998/WHO_HGN_GL_ETH_98.1.pdf.
26. The Bioethics Advisory Committee: Genetic testing and genetic research. Singapore: The Bioethics Advisory Committee, 2005.HAvailable from: http://www.bioethics-singapore.org/resources/pdf/GTGR%20Report.pdf.
27. Consortium on Pharmacogenetics: Ethical and regulatory issues in research and clinical practice. Minneapolis: Consortium on Pharmacogenetics, 2002. Available from: http://www.bioethics.umn.edu/ News/pharm_report.pdf.
28. Anderson DC, Gomez-Mancilla B, Spear BB et al: Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group. Pharmacogenomics J 2002; 2: 284-292.
29. Medical Research Council (MRC): Human tissue and biological samples for use in research - operational and ethical guidelines. London: Medical Research Council, 2001. Available from: http://www.mrc.ac.uk/ pdf-tissue_guide_fin.pdf.
30. Pinsky L, Atkins D, Ramsey S, Burke W: Developing guidelines for the clinical use of genetic tests: A US perspective; in Khoury MJ, Burke W, Little J (eds): HumanAgenome epidemiology: a scientific foundation for using genetic information to improve health and prevent disease. Oxford: Oxford university Press, 2003.
31. Clarke A, English V, Harris H, Wells F: Ethical considerations. Int J Pharmaceutical Med 2001; 15: 89-94.
32. US Department of health and human services: Medicare, Medicaid and CLIA programs: Laboratory requirements relating to quality systems and certain personnel qualifications. Final rule. Fed Regist 2003; 68: 3640-3714, Available from: www.phppo.cdc.gov/clia/pdf/CMS-2226-F.pdf.
33. Quaid KA, Jessup NM, Meslin EM: Disclosure of genetic information obtained through research. Genet Testing 2004; 8: 347-355.
34. American Society of Human Genetics (ASHG): DNA banking and DNA analysis: points to consider. Bethesda: American Society of Human Genetics, 1988. Available from: http://genetics.faseb.org/genetics/ashg/policy/ pol-02.htm.
35. Canadian College of Medical Geneticists: Policy statement concerning DNA banking and molecular genetic diagnosis. Clin Invest Med 1991; 14: 363-365.
36. Quebec Network of Applied Genetic Medicine (RMGA): Statement of principles: Human genomic research. Montreal: Quebec Network of Applied Genetic Medicine, 2000. Available from: http://www.rmga.qc.ca/doc/ principes_en_2000.html.
37. National Consultative Ethics Committee for Health and Life Sciences: Opinion and recommendations on 'genetics and medicine: From prediction to prevention'. Paris: National Consultative Ethics Committee for Health and Life Sciences, 1995. Available from: http://www.ccne-ethique.fr/ english/start.htm.
38. Human Genome Organisation (HUGO): Statement on the principled conduct of genetic research. London: Human Genome Organisation, 1996. Available from: http://www.gene.ucl.ac.uk/hugo/conduct.htm.
39. Human Genome OrganisaCion (HUGO): Statement on DNA sampling: control and access. London: Human Genome Organisation, H998. Available from: http://www.gene.ucl.ac.uk/hugo/sampling.html.
40. World Medical Association (WMA): Declaration on the human genome project. Marbella: World Medical Association, 1992. Available from: http://www.wma.net/e/policy/g6.htm.